the A549 lung cancer cell line and the HCT116 colon
cancer cell line at 100 μg/mL. However, tripartilactam was
þ
þ
observed to be a moderate inhibitor of Na /K ATPase,
with an IC50 value of 16.6 μg/mL.
The structure of 1 is unique because of the existence of
cyclobutane linking the 8- and 18-membered rings. This
ring structure could be formed by a photochemically
1
4
derived [2 þ 2] cycloaddition reaction of the two double
bonds at positions 8 and 16 in a putative macrocyclic
lactam precursor (see SI Figure S3).
Figure 4. ΔδS-R values in ppm for the S- and R-PGME amide
products (4a and 4b) in CD OD.
3
The absolute configurations of the stereogenic centers in
cyclobutane and cyclooctene were determined by the
application of the modified Mosher method using (R)-
and (S)-R-methoxy-(trifluoromethyl) phenyl acetyl chlo-
ride (MTPA-Cl). Since tripartilactam bears three consecu-
tive hydroxy groups at C-11, C-12, and C-13, it was
challenging to generate mono-MTPA esters. After a sig-
nificant amount of effort on reaction optimization, we
tried a short reaction time (5 min) and succeeded in ob-
taining mono-(S)- and (R)-MTPA ester selectively at the
Figure 5. ΔδS-R values in ppm for the S- and R-MTPA esters (5a
and 5b) in DMSO-d6.
1
alcohol of C-13 (5a and 5b). Analysis of H NMR and
COSY spectral data for these MTPA esters allowed the
assignment of the ΔδS-R values, which sufficiently estab-
Four- and eight-membered bicyclic structures have been
13
1
reported in terpenoids from terrestrial plants and marine
5
lished the absolute configuration of C-13 as 13R (Figure 5).
1
6
Based on the relative configuration, the absolute config-
urations of the chiral centers C-8, C-9, C-11, C-12, C-16,
and C-17 were determined as 8R, 9R, 11R, 12R, 16R,
and 17S.
The biological activity of 1 was evaluated first in cell-
based antimicrobial and anticancer assays, in which no
significant inhibition against various pathogenic bacterial
and fungal strains was observed (see Supporting Informa-
tion (SI)). This compound was also inactive against
soft corals. However, the 4-, 8-, and 18-membered tri-
cyclic structure of 1 is an unprecedented carbon skeleton,
to the best of our knowledge.
The discovery of tripartilactam with a novel carbon
scaffold provides additional evidence that microbial com-
munities of insect habitats could be promising sources of
structurally novel bioactive natural products.
Acknowledgment. The authors thank Professors Sanghee
Kim in SNU, Yousung Jung in KAIST, and Michael
Fischbach in UCSF for valuable discussions about cyclobu-
tane ring formation. This work was supported by the National
Research Foundation of Korea (NRF) grants funded by the
Korean government (MEST) (No. 2011-0015931) and (No.
(
13) Seco, J. M.; Qui n~ o ꢀa , E.; Riguera, R. Tetrahedron: Asymmetry
001, 12, 2915.
14) We propose that this [2 þ 2] cycloaddition is photochemically
derived because we could not find any precedent example of enzymatic
2
(
[
2 þ 2] cycloaddition thus far to the best of our knowledge. However, we
could not completely exclude the possibility of the enzymatic involve-
ment in this thermally forbidden reaction. For the general mechanism of
photochemical [2 þ 2] cycloaddition, see: Carruthers, W. Cycloaddition
Reactions in Organic Synthesis; Pergamon Press: 1991; p 322. For another
possible cyclobutane formation mechanism by unusual oxidative cycli-
zation or radical cascading proposed in the ladderane biosynthesis, see:
Rattary, J. E.; Strous, M.; Op den Camp, H. J. M.; Schouten, S.; Jetten,
M. S. M.; Damst ꢀe , J. S. S. Biol. Direct 2009, 4, 8.
2011-0030635). D.C.O. is a Howard Hughes Medical Institute
International Early Career Scientist.
Supporting Information Available. Experimental section,
bioassay data, a proposed biosynthetic pathway of 1, and
NMR spectra of 1, 3, 4a, 4b, 5a, and 5b. This material is
available free of charge via the Internet at http://pubs.acs.org.
(15) (a) Jacobsson, U.; Kumar, V.; Saminathan, S. Phytochemistry
1
1
995, 39, 839. (b) Macleod, J. K.; Rasmussen, H. B. Phytochemistry
999, 50, 105.
(
16) (a) Sung, P.-J.; Chuang, L.-F.; Kuo, J.; Chen, J.-J.; Fan, T.-Y.;
Li, J.-J.; Fang, L.-S. Chem. Pharm. Bull. 2007, 55, 1296. (b) Groweiss, A.;
Kashman, Y. Tetrahedron 1983, 39, 3385.
The authors declare no competing financial interest.
Org. Lett., Vol. 14, No. 5, 2012
1261